Parkinson's Disease Trial, Not Yet Recruiting NCT07725315 Sponsor: University of Alabama at Birmingham Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07725315
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between 30 and 80 years of age.
  • People who have already decided to have deep brain stimulation (DBS) surgery as part of their normal medical care.
  • People who have been approved for DBS surgery by a specialist movement disorders committee as part of their routine care.
  • People with persistent movement problems — such as involuntary movements, medication wearing off too soon, or unpredictable changes in movement control — that cause significant disability despite trying reasonable medical treatments, as determined by the DBS committee.
  • People who are able to walk on their own.
  • People who are available for follow-up appointments throughout the length of the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose health insurance will not cover the costs of surgery involving investigational (research) devices.
  • People with certain medical conditions that make DBS surgery or stimulation unsafe, such as uncontrolled high blood pressure, heart disease, blood clotting problems, or similar conditions.
  • People who report that the medication levodopa has not clearly helped their symptoms.
  • People who need a walker or wheelchair to get around.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2059345817

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Self-Reported Falls

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov